Celltrion Holdings IPO
Scope
Date
~
-
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Nov 10, 2023 (Gmt+09:00)
-
Batteries
POSCO Holdings to secure lithium from oil-field brine in Canada
South Korea's POSCO Holdings Inc. announced on Wednesday it signed a memorandum of understanding (MOU) with Invest Alberta Corporation (IAC) in Seou...
Nov 08, 2023 (Gmt+09:00)
-
Earnings
Celltrion enjoys record earnings on healthy biosimilar biz
South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...
Nov 07, 2023 (Gmt+09:00)
-
Fashion
The Nature Holdings goes after green fashion with Brompton
Brompton Bicycle will pursue a greener world with sustainable clothing that is stylish but durable alongside its Korean partner The Nature Holdings ...
Nov 07, 2023 (Gmt+09:00)
-
Korean games
S.Korea seeks to sell 29% in game giant Nexon's holding firm
The South Korean government is planning to sell off a 29.3% stake in Tokyo-listed game giant Nexon Co.’s holding firm NXC Corp. via a public b...
Nov 06, 2023 (Gmt+09:00)
-
Entertainment
K-pop fan platform company DearU to enter into Japan
DearU Co., a K-pop fandom platform in South Korea, announced the launch of the Japanese version of "bubble" on Tuesday. DearU bubble is a private me...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Construction
KKR expected to buy 100% stake in Taeyoung Industry
Global private equity giant KKR & Co. Inc. is expected to take over Taeyoung Industry Corp., a cash cow of South Korea’s medium-sized busi...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
IPOs
LS Materials seeks November listing in $60 mn IPO
LS Materials Co., a South Korean energy storage devices maker, on Monday submitted a securities report to the Korea Exchange for an initial public o...
Oct 23, 2023 (Gmt+09:00)
-
Future mobility
Pablo Air secures $15.5 mn in pre-IPO investment
Pablo Air Co. Ltd., a specialized drone control company, announced on Friday that it has attracted an investment of 21 billion won ($15.5 million) i...
Oct 20, 2023 (Gmt+09:00)
-
IPOs
Tesla supplier L&F's precursor unit begins IPO process
L&F Co., a South Korean electric vehicle battery materials supplier to Tesla Inc., has embarked on a process to list its subsidiary in the local...
Oct 18, 2023 (Gmt+09:00)
-
Korean chipmakers
SK Hynix may block Kioxia-Western Digital merger
South Korean memory chip giant SK Hynix Inc. is rumored to be frowning on the integration of Japan’s Kioxia Holdings Corp. with US-based Weste...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to US pharmacy chain
South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...
Oct 16, 2023 (Gmt+09:00)
-
Automobiles
Kia holds first Global Distributors Convention in 5 years
South Korea's Kia Corp. held a global distributors convention for the first time in five years, sharing medium to long-term business strategies, inc...
Oct 13, 2023 (Gmt+09:00)
-
Banking & Finance
Hyundai Capital to acquire Indonesian financial firm
South Korea's Hyundai Capital announced on Wednesday it will acquire the Indonesian finance firm PT Paramitra Multifinance to enter the local market...
Oct 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Proxy adviser ISS backs drug giant Celltrion's merger plan
South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...
Oct 06, 2023 (Gmt+09:00)
-
Food & Beverage
Daesang holds kimchi pop-up event in Seoul
South Korean food company Daesang Corp. on Friday said it is holding through Oct. 15 the country’s first kimchi pop-up store “Kimchi Bla...
Oct 06, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Doosan Robotics looks for M&A targets post-IPO: CEO
When Ryu Junghoon was tapped as chief executive of Doosan Robotics Inc. two years ago, he vowed to turn the young robot-making company into an indus...
Oct 04, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom enters Japan's pet care market
South Korea’s SK Telecom Co. has entered the Japanese pet market using its innovative artificial intelligence (AI) under a tie-up with Japan&r...
Oct 04, 2023 (Gmt+09:00)
-
Electric vehicles
POSCO Int’l to build permanent magnet factory in US with Star Group
South Korea’s steel giant POSCO Holdings Inc. is expediting its push to expand its presence in the electric vehicle supply chain, one of seven...
Oct 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets sales approval for Yuflyma in Japan
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...
Sep 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion signs largest-ever quarterly deal with global sales affiliate
Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its larges...
Sep 25, 2023 (Gmt+09:00)
-
Bio & Pharma
CJ CheilJedang searches for global bio talent in Boston
South Korean food and bio giant CJ CheilJedang Corp. on Monday said its Chief Technology Officer Hwang Yun-il, CJ CheilJedang BIO executive Yoon Seo...
Sep 25, 2023 (Gmt+09:00)
-
IPOs
Doosan Robotics attracts $24.8 billion from retail investors in IPO deposits
Doosan Robotics Inc., a unit of South Korea’s Doosan Group, has attracted billions of dollars from retail investors in subscription deposits f...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to five regional gov’ts in Italy
South Korea's Celltrion Healthcare Co. announced on Monday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatm...
Sep 18, 2023 (Gmt+09:00)
-
Fintech
Alipay’s Ant becomes No.2 shareholder of S. Korea’s Toss Payments
Ant Group Co., the operator of China’s biggest mobile payment platform Alipay, has become the second-largest stakeholder of Toss Payments, the...
Sep 18, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand